Modafinil: Underarousal,Somnolence,and Fatigue Related to Brain Injury

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Pacts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Pacts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@kumc.edu.

Get full access to this article

View all access options for this article.

References

Bay

de-Leon

M.B.

Chronic stress and fatigue-related quality of life after mild to moderate traumatic brain injury. J Head Trauma Rehabil. 2011; 26(5): 355–363.

Cantor

J.B.

Ashman

Gordon

Fatigue after traumatic brain injury and its impact on participation and quality of life. J Head Trauma Rehabil. 2008; 23(1): 41–51.

Elovic

Use of provigil for underarousal following TBI. J Head Trauma. 2000; 15(4): 1068–1071.

Jha

Weintraub

Allshouse

A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J Head Trauma Rehabil. 2008; 23(1): 52–63.

Cochran

J.W.

Effect of modafinil on fatigue associated with neurological illnesses. J Chronic Fatigue Syndr. 2001; 8(2): 65–70.

Brain Trauma Foundation. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007; 24(suppl 1): S1–S106.

Kaiser

P.R.

Valko

P.O.

Werth

Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury. Neurology. 2010; 75(20): 1780–1785.

Teitelman

Off-label uses of modafinil. Am Psychiatry. 2001; 158(8): 1341.